| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Revenue | $1.90B | +30.5% |
| Cost of Revenue | $1.62B | +23.2% |
| Gross Profit | $287.0M | +95.2% |
| R&D Expense | $21.6M | +52.5% |
| SG&A Expense | $96.9M | +44.7% |
| Operating Income | $168.5M | +155.6% |
| Pre-tax Income | $169.1M | +159.7% |
| Income Tax | $47.8M | +236.4% |
| Net Income | $1.1M |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $130.0M | +347.2% |
| Accounts Receivable | $271.2M | +61.1% |
| Inventory | $138.1M | -19.8% |
| Current Assets | $872.3M | +22.2% |
| Total Assets | $1.42B | +39.6% |
| Current Liabilities | $507.4M | +7.2% |
| Long-term Debt | $147.1M | — |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $107.7M | +173.2% |
| Capital Expenditures | $3.2M | -46.2% |
| Investing Cash Flow | -$3.2M | +45.1% |
| Financing Cash Flow | -$3.6M | +58.7% |
| Free Cash Flow | $104.5M | +168.3% |
| — |
| EPS (Basic) | $0.02 | — |
| EPS (Diluted) | $0.02 | — |
| Total Liabilities |
| $934.8M |
| +81.1% |
| Stockholders' Equity | -$3.08B | — |